The FDA is seeking feedback on its document entitled Decentralized Clinical Trials for Drugs, Biological Products, and Devices Guidance for Industry, Investigators, and Other Stakeholders – this draft Guidance is available at https://www.regulations.gov/document/FDA-2022-D-2870-0002. The deadline to submit comments is August 1.
Register for the 2023 N2 Eastern Regional Meeting!
Registration for the 2023 N2 Eastern Regional Meeting is now open! Register today View the agenda here.
